跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HETEVIR tenofovir disoproxil fumarate 300mg tablets blister - TGA Drug Approval Details
Approvals
/
TGA
/
HETEVIR tenofovir disoproxil fumarate 300mg tablets blister
Approved
STANDARD
HETEVIR tenofovir disoproxil fumarate 300mg tablets blister
Hetero Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
6782b91fd2781b9d
Company
Hetero Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
6782b91fd2781b9d
Product Name
HETEVIR tenofovir disoproxil fumarate 300mg tablets blister
Artg Id
295603
Artg Name
HETEVIR tenofovir disoproxil fumarate 300mg tablets blister
Sponsor
Hetero Australia Pty Ltd
Company Detail Path
/organization/hetero-australia-pty-ltd
Artg Date
2018-12-06
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
6782b91fd2781b9d
Type
Standard
Back to TGA Approvals
